Top Highlights
- 10x Genomics launched the Atera, a groundbreaking spatial instrument that enables whole-transcriptome analysis at scale, surpassing previous tradeoffs in plex, throughput, and sensitivity.
- Atera offers four times the throughput, six times higher plex capacity, and 2-3x sensitivity, revolutionizing spatial genomics and opening new avenues in tissue and cellular research.
- The platform’s ability to use standard slides and its high cellular and tissue coverage make it pathology-friendly and highly applicable for oncology and large-scale studies like the Human Cell Atlas.
- Positioned as a fundamental, future-proof platform, Atera will accelerate large data projects, advance spatial proteomics, and shape the next decade of biological discovery.
Major Unveiling at the AACR Meeting
At the recent AACR conference in San Diego, a significant breakthrough in cancer research was announced. 10x Genomics revealed its newest platform, called Atera, at a lively event near the conference center. The company’s CEO emphasized that the Atera platform addresses a major need in the field—accurately studying tissues at a detailed level. This launch marks a milestone, as it promises to advance how scientists analyze biology. The platform is designed to provide a clearer picture of genes within tissues, moving beyond the limitations of previous tools. Researchers see this as a step toward more precise cancer knowledge, which could lead to better treatments and understanding of the disease’s complexities.
What Makes Atera a Game-Changer?
Atera is packed with features that set it apart from earlier technologies. Compared to similar platforms, it offers four times the throughput—the speed at which it processes samples—and significantly higher capacity for studying many genes at once. It is also more sensitive, capable of analyzing whole transcriptomes with greater detail. The system uses common glass slides, making it easier for scientists to collaborate and integrate with existing methods. Although the price of nearly half a million dollars might seem steep, the device can handle up to 800 tissue samples per year, which helps researchers study cancer and other diseases more efficiently. Industry experts highlight that this system eliminates previous tradeoffs between detail and breadth, promising a new era of comprehensive tissue analysis that was once thought impossible.
Discover More Technology Insights
Learn how the Internet of Things (IoT) is transforming everyday life.
Learn more about cutting-edge innovations supported by the National Science Foundation (NSF).
Sci-BioV1
